• 1.

    Floege J, et al. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2019; 95:268280.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Rovin BH, et al. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2019; 95:281295.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Goodship TH, et al. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int 2017; 91:539551.

    • Crossref
    • Search Google Scholar
    • Export Citation

KDIGO Quo Vadis: Updating Guidance for the Management and Treatment of Glomerulonephritis

  • 1 Jürgen Floege, MD, PhD, is director of the Division of Nephrology, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany. Brad H. Rovin, MD, is director of the Division of Nephrology, Wexner Medical Center at Ohio State University, Columbus, USA.
Restricted access
Save